Enterprise Tech Ecosystem Series: Haleon - 2025

Haleon is a British consumer health company with an extensive product portfolio. The company categorized its brands into five categories namely, Oral Health; Pain; Vitamins, Minerals and Supplements (VMS); Respiratory; and Digestive and Other. Its Oral Health product portfolio includes Sensodyne, Polident, Parodontax, Biotene, and Aquafresh. Its Pain relief product portfolio includes Panadol, Voltaren, and Advil. Its VMS product portfolio includes Centrum, Caltrate, and Emergen-C. Its Digestive and Other product portfolio includes TUMS, ENO, and Fenistil. Its Respiratory product portfolio includes Otrivine, Flonase, and Theraflu. Haleon’s products are available in North America, the Asia-Pacific region (APAC), Europe, the Middle East and Africa (EMEA) region, and Latin America (LATAM).

The report provides information and insights into Haleon's tech activities, including:

• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships, and product launches.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets.

Scope

• The report provides insights into the company’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

Reasons to Buy

• Gain insights into Haleon's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches and partnerships.